Talk to AdAlta Limited directly.
Sign up to their Investor Hub for direct access to the AdAlta Limited team, ask them questions, and see personal updates.
AdAlta is an innovative biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and then developed as a human protein. The result is a range of unique compounds, now known as i-bodies, for use in treating serious diseases. AdAlta is utilising the power of the i-body technology to create a pipeline of new drugs, with an initial focus on treating fibrotic diseases.
15/2 Park Dr, Bundoora VIC 3086, Australia
Earnings per share
Dividend per share